Soley Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeSoley Therapeutics
Soley Therapeutics logo

Soley Therapeutics

0 followers

About Soley Therapeutics

Soley Therapeutics is a science-first, tech-enabled biotechnology company that uses whole-cell sensing to translate cellular responses under stress and drug exposure into medicines. Leveraging proprietary imaging, automation, and computational analysis, they uncover how living cells decide to adapt, recover, or die to inform the discovery and development of first-in-class therapeutics. Based in South San Francisco, California, the company focuses on oncology and non-oncology complex diseases, aiming to accelerate translation from biology to clinic.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Kurosh Ameri, PhD

Co-Founder, CSO

Paul Woodard, M.D.

Chief Medical Officer

Yerem Yeghiazarians, MD

Co-Founder, CEO

Mehrdad Hamadani

CTO, EVP Engineering, AI, and Operations

Sheerin Latham, Ph.D.

Head, Non-Clinical Drug Development

Key Facts

HQ Location

South San Francisco, United States

Founded

2020

Employees

11 - 50

Status

Private

Website

https://soleytherapeutics.com